Floatz logo

Autologous Nk Cells

Persistent/Recurrent Minimal Residual Disease (MRD)

Gruppo Italiano Malattie EMatologiche dell'AdultoCell therapyPhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Persistent/Recurrent Minimal Residual Disease (MRD) cohort.

Asset / SponsorPhaseRating

Same molecule, other indications

Autologous Nk Cells is also rated in:

non-small cell lung carcinomaDormant
B
Indicative ·
57 / 100
View asset →
hepatocellular carcinomaDormant
CC
Indicative ·
43 / 100
View asset →
squamous cell lung carcinomaDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →